GSK Tres Cantos

GlaxoSmithKline R&D, Tres Cantos Site

GSK is a global healthcare company with a long-standing commitment to develop new treatments and vaccines for diseases specifically affecting developing countries, and has pioneered a number of approaches to try to stimulate research in this area.

Through the Open Laboratory initiative, GSK collaborates on research into fighting these diseases and will help the partners to direct their activities towards therapeutic intervention. Research partners will therefore be able to gain access to facilities and drug discovery expertise, and expand capabilities in hit identification, lead optimisation and early clinical development. Everyone involved will be dedicated to finding new small molecules for tackling diseases of the developing world.